慢性便秘的非药物治疗 慢性便秘的非药物治疗
Myeongsook Seo1, June Hwa Bae2
1Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
概括
这项研究审查了功能性便秘的非药物治疗方法,这种疾病在全球影响了14%. 它强调了生活方式的改变和生物反等疗法作为有效的初始管理策略.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 物理医学和康复 康复
背景情况:
- 功能性便秘影响全球14%的人口,需要有效的管理策略.
- 非药物干预,包括改变生活方式,是主要的治疗方法.
- 当保守措施失败时,需要考虑药理选择.
研究的目的:
- 提供功能性便秘的非药物治疗方法的概述.
- 强调生活方式调整和先进的非药物治疗的作用.
主要方法:
- 对功能性便秘的非药物治疗的文献综述.
- 讨论饮食变化,身体活动和特定疗法.
- 分析生物反治疗在异能排便中的疗效.
主要成果:
- 非药物疗法,如饮食和运动,是最初的管理步骤.
- 生物反疗法在慢性便秘中常见的异能排便中显示出高效和安全性.
- 对于耐火病例,可以选择先进的选择,如手术和十字神经刺激.
结论:
- 非药物治疗对于管理功能性便秘至关重要.
- 生物反疗法是一种高度有效的治疗不协同排便.
- 综合生活方式变化和向治疗的综合方法可以改善患者的治疗结果.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
203
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
203
Drugs Affecting GI Tract Motility: Other Laxatives
197
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
197
Drugs for Treatment of Diarrhea-Predominant IBS
160
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
160
Irritable Bowel Syndrome III: Medical and Nursing Management
195
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
195
Inflammatory Bowel Disease V: Surgical Management
144
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
144


